Cargando…
Treatment with FTY720 has no beneficial effects on short-term outcome in an experimental model of intracerebral hemorrhage
BACKGROUND: No evidence-based therapy is available for patients with acute intracerebral hemorrhage (ICH). In view of the profound inflammatory reaction in the perilesional tissue, we investigated in a well-characterized experimental model whether the administration of the immunomodulator fingolimod...
Autores principales: | Schlunk, Frieder, Pfeilschifter, Waltraud, Yigitkanli, Kazim, Lo, Eng H., Foerch, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758011/ https://www.ncbi.nlm.nih.gov/pubmed/26893821 http://dx.doi.org/10.1186/s13231-016-0016-z |
Ejemplares similares
-
Coadministration of FTY720 and rt-PA in an experimental model of large hemispheric stroke–no influence on functional outcome and blood–brain barrier disruption
por: Cai, Aijia, et al.
Publicado: (2013) -
Treatment with the immunomodulator FTY720 does not promote spontaneous bacterial infections after experimental stroke in mice
por: Pfeilschifter, Waltraud, et al.
Publicado: (2011) -
FTY720 Treatment in the Convalescence Period Improves Functional Recovery and Reduces Reactive Astrogliosis in Photothrombotic Stroke
por: Brunkhorst, Robert, et al.
Publicado: (2013) -
Intravenous tPA Therapy Does Not Worsen Acute Intracerebral Hemorrhage in Mice
por: Foerch, Christian, et al.
Publicado: (2013) -
FTY720-derivatives do not induce FTY720-like lymphopenia
por: Segura-Ulate, Ismael, et al.
Publicado: (2017)